Sanjay Sharma, MD
Nephrology · Stockbridge, GANPI 1760455125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Amgen at 59.7% of the total. Reporting peaked in 2021 at $197 and has fallen 83.2% since, to $33 in 2025. That places this record below the midpoint for nephrology clinicians in GA, where the typical reported total is $1,554.
Across 35 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$274
- Novo Nordisk$35
- Akebia Therapeutics Inc$30
- Otsuka America Pharmaceutical, Inc.$23
- Travere Therapeutics, Inc.$22
- Medtronic$20
- plus $54 from 3 others
What the payments were for
- Food & beverage$41791%
- Education$429%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 17 | $274 |
| Novo Nordisk | 2 | $35 |
| Akebia Therapeutics Inc | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $23 |
| Travere Therapeutics, Inc. | 9 | $22 |
| Medtronic | 1 | $20 |
| Shockwave Medical, Inc | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| AstraZeneca | 1 | $14 |
How this compares
$459 in reported general payments places this provider in the 25th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProsolParenteral Amino Acid 20% No.1 | 136 | $23,769 |
| Sevelamer Carbonate | 48 | $7,820 |
| Nifedipine ErNifedipine | 253 | $7,332 |
| Calcium Acetate | 75 | $6,414 |
| Paricalcitol | 24 | $4,012 |
| Cinacalcet Hcl | 13 | $2,271 |
| Potassium Citrate ErPotassium Citrate | 11 | $2,182 |
| Calcitriol | 98 | $1,633 |
| Spironolactone | 144 | $1,629 |
| Losartan Potassium | 238 | $1,500 |
| Carvedilol | 189 | $1,293 |
| Allopurinol | 106 | $1,039 |
| Doxazosin Mesylate | 61 | $966 |
| Sodium Polystyrene Sulfonate | 19 | $950 |
| Valsartan | 26 | $930 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Stockbridge
- Sagar PanseMacon$542K
- Sheldon ShoreAtlanta$474K
- James TumlinLawrenceville$434K
- Salvatore ChillemiMarietta$287K
- Christina KleinAtlanta$137K
- Mary MuonekeAtlanta$119K
- Don WilliamsonAugusta$104K
- Frederic Rahbari OskouiAtlanta$88K
- Rajendran AlappanColumbus$87K
- William PaxtonLawrenceville$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.